Gala NAD+ vs Embody NAD+
Both brands describe prescription compounded NAD+ after an online intake. The published prices, the visit style, and the link status are different. Only Gala’s NAD+ offer is joined, so the button on this page opens Gala and says so.
Joined prescription NAD+ program. Gala describes at-home subcutaneous injections after an async provider review. You will leave DoctorsHome for the program’s own site. A clinician there decides whether to prescribe.
Program terms list the United States and Canada. Eligibility is adults 18 and older, and some states set a higher minimum age.
DoctorsHome is an independent publisher, not a medical practice. Some buttons are paid affiliate links. If you enroll through one, we may earn a commission. That does not change the price the program charges, and it is not a statement that a medication is right for you.
What it is
Compounded NAD+ as a subcutaneous injection you take at home if prescribed.
Embody NAD+
Compounded NAD+ injections. The product page says the clinician sets the dose.
Published price
From $149 per month for 28 days, or $119 per month on the 3-month plan. Charged at checkout.
Embody NAD+
Product page showed $49 on sale and $149 regular. Program materials have also described other monthly rates. Checkout wins.
Visit
Async review, about 5–7 minutes, no video required. Up to a 3-month supply, then a quarterly check-in.
Embody NAD+
Online intake and a licensed clinician’s review. The page does not promise a video-free visit in every state.
If not prescribed
Gala says you are refunded in full.
Embody NAD+
Product page says refund if medically disqualified.
Where
Terms list the U.S. and Canada. Adults 18+, with a higher minimum age in some states.
Embody NAD+
Product page says the program may not be available in all states.
Link on this site
Joined. The button opens Gala’s tracking URL.
Embody NAD+
Pending. No Embody tracking URL is rendered.
How to read the gap
A lower sticker price is not evidence of a better clinical fit. Gala’s $119 figure is a 3-month plan price, not a promise that every refill stays there. Embody’s $49 figure was a sale price next to $149. Either number can change before you pay.
Neither page proves that an injection will raise energy or sharpen focus. NAD+ declines with age. That is a reason the products exist. It is not a personal outcome. Compounded NAD+ is not an FDA-approved finished drug on either site.
Screening Gala publishes
Gala says NAD+ is not appropriate at a hematocrit of 52 percent or higher, or with a known NAD allergy. It also says a GLP-1/GIP prescription that already contains nicotinamide riboside can block a separate NAD+ prescription. Embody’s product page leaves those screens to the clinician and does not list the same hematocrit cutoff in the copy we reviewed.
Questions
Which link should I use?
If you use a button on DoctorsHome, it opens Gala NAD+, because that offer is joined. Embody NAD+ is pending, so we do not attach an Embody tracking link and then label it as a choice.
Are the products identical?
Both are compounded NAD+ prescribed to an individual. Pharmacies, doses, and supplies can differ. The clinician and the pharmacy, not this comparison, decide what is dispensed.
Keep reading
The affiliate button names Gala and uses the joined NAD+ tracking link. Embody’s URL is not in the page.
DoctorsHome publishes independent guides to telehealth programs. It is not a medical practice, clinic, pharmacy, or telehealth service. It does not diagnose, prescribe, or ship medication, and it is not a substitute for a licensed clinician.
Some buttons are paid affiliate links to Gala Health. If you enroll, we may earn a commission. That does not change the program’s price and it is not a medical endorsement. Pending programs are not linked. Compounded medicines are not FDA-approved finished drugs. Availability depends on the program and your state.
Nothing here is for emergencies. Call 911 for a medical emergency. If you are in a mental-health crisis, call or text 988.